Rabobank, Wells Increase Nutraceutical Credit Line
Nutraceutical increased its revolver to $100 million with a $30 million accordion feature. Rabobank will continue as lead bank, and Wells Fargo will remain as a lender and is currently the primary U.S. commercial banking partner.
November 6, 2014
Neutraceutical | Rabobank
ABF Journal